 | • レポートコード：MRC2Q12-16825 • 出版社/出版日：QYResearch / 2022年12月 • レポート形態：英文、PDF、128ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医療 |
| Single User | ￥725,200 (USD4,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,450,400 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| コロナ禍により、プラスミドDNA生産の世界市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にプラスミドDNA生産のグローバル市場のxxx％を占める「前臨床プラスミド」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「商業用」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。 プラスミドDNA生産の中国市場規模は2021年にUS$xxxと分析されており、アメリカとヨーロッパの市場規模はそれぞれUS$xxxとUS$xxxです。アメリカの割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパのプラスミドDNA生産市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。 プラスミドDNA生産のグローバル主要プレイヤーには、Charles River、Lonza、Aldevron、Thermo Fisher Scientific、Catalent、The Discovery Labs、BIOCENTRIQ、FUJIFILM Diosynth Biotechnologies、Exothera、WuXi AppTec、Pharmaron、OBiO、Cell Therapies、AGC Biologics、Cytiva、Helixmith、ThermoGenesis、Anemocyte、CBM、Bio Elpida、Genezen、CCRM、RoslinCT、GenScript ProBio、Oxford BioMedica、Porton Pharma Solutionsなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 プラスミドDNA生産市場は、種類と用途によって区分されます。世界のプラスミドDNA生産市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。 【種類別セグメント】 前臨床プラスミド、臨床プラスミド、商用プラスミド 【用途別セグメント】 商業用、学術研究、その他 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - プラスミドDNA生産製品概要 - 種類別市場（前臨床プラスミド、臨床プラスミド、商用プラスミド） - 用途別市場（商業用、学術研究、その他） - 調査の目的 ・エグゼクティブサマリー - 世界のプラスミドDNA生産販売量予測2017-2028 - 世界のプラスミドDNA生産売上予測2017-2028 - プラスミドDNA生産の地域別販売量 - プラスミドDNA生産の地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別プラスミドDNA生産販売量 - 主要メーカー別プラスミドDNA生産売上 - 主要メーカー別プラスミドDNA生産価格 - 競争状況の分析 - 企業M&A動向 ・種類別市場規模（前臨床プラスミド、臨床プラスミド、商用プラスミド） - プラスミドDNA生産の種類別販売量 - プラスミドDNA生産の種類別売上 - プラスミドDNA生産の種類別価格 ・用途別市場規模（商業用、学術研究、その他） - プラスミドDNA生産の用途別販売量 - プラスミドDNA生産の用途別売上 - プラスミドDNA生産の用途別価格 ・北米市場 - 北米のプラスミドDNA生産市場規模（種類別、用途別） - 主要国別のプラスミドDNA生産市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパのプラスミドDNA生産市場規模（種類別、用途別） - 主要国別のプラスミドDNA生産市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋のプラスミドDNA生産市場規模（種類別、用途別） - 主要国別のプラスミドDNA生産市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米のプラスミドDNA生産市場規模（種類別、用途別） - 主要国別のプラスミドDNA生産市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカのプラスミドDNA生産市場規模（種類別、用途別） - 主要国別のプラスミドDNA生産市場規模（トルコ、サウジアラビア） ・企業情報 Charles River、Lonza、Aldevron、Thermo Fisher Scientific、Catalent、The Discovery Labs、BIOCENTRIQ、FUJIFILM Diosynth Biotechnologies、Exothera、WuXi AppTec、Pharmaron、OBiO、Cell Therapies、AGC Biologics、Cytiva、Helixmith、ThermoGenesis、Anemocyte、CBM、Bio Elpida、Genezen、CCRM、RoslinCT、GenScript ProBio、Oxford BioMedica、Porton Pharma Solutions ・産業チェーン及び販売チャネル分析 - プラスミドDNA生産の産業チェーン分析 - プラスミドDNA生産の原材料 - プラスミドDNA生産の生産プロセス - プラスミドDNA生産の販売及びマーケティング - プラスミドDNA生産の主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - プラスミドDNA生産の産業動向 - プラスミドDNA生産のマーケットドライバー - プラスミドDNA生産の課題 - プラスミドDNA生産の阻害要因 ・主な調査結果 |
Report Overview
Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Plasmid DNA Production estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028.
The USA market for Plasmid DNA Production is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The China market for Plasmid DNA Production is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The Europe market for Plasmid DNA Production is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The global key companies of Plasmid DNA Production include Charles River, Lonza, Aldevron, Thermo Fisher Scientific, Catalent, The Discovery Labs, BIOCENTRIQ, FUJIFILM Diosynth Biotechnologies and Exothera, etc. In 2021, the global top five players had a share approximately % in terms of revenue.
Report Scope
This latest report researches the industry structure, revenue and gross margin. Major players’ headquarters, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Plasmid DNA Production companies, distributors, end users, industry associations, governments’ industry bureaus, industry publications, industry experts, third party database, and our in-house databases.
This report also includes a discussion of the major players across each regional Plasmid DNA Production market. Further, it explains the major drivers and regional dynamics of the global Plasmid DNA Production market and current trends within the industry.
Key Companies Covered
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable revenue, market share and rank data of the companies for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
Charles River
Lonza
Aldevron
Thermo Fisher Scientific
Catalent
The Discovery Labs
BIOCENTRIQ
FUJIFILM Diosynth Biotechnologies
Exothera
WuXi AppTec
Pharmaron
OBiO
Cell Therapies
AGC Biologics
Cytiva
Helixmith
ThermoGenesis
Anemocyte
CBM
Bio Elpida
Genezen
CCRM
RoslinCT
GenScript ProBio
Oxford BioMedica
Porton Pharma Solutions
Market Segments
This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides revenue forecast data by type and by application segments based on value for the period 2017-2028.
Plasmid DNA Production Segment by Type
Preclinical Plasmid
Clinical Plasmid
Commercial Plasmid
Plasmid DNA Production Segment by Application
Commercial
Academic Research
Others
Key Regions & Countries
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value data of each region and country for the period 2017-2028.
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Plasmid DNA Production market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Report Includes:
This report presents an overview of global market for Plasmid DNA Production market size. Analyses of the global market trends, with historic market revenue data for 2017 – 2021, estimates for 2022, and projections of CAGR through 2028.
This report researches the key producers of Plasmid DNA Production, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Plasmid DNA Production, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Plasmid DNA Production revenue, market share and industry ranking of main companies, data from 2017 to 2022. Identification of the major stakeholders in the global Plasmid DNA Production market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2017 to 2028. Evaluation and forecast the market size for Plasmid DNA Production revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Charles River, Lonza, Aldevron, Thermo Fisher Scientific, Catalent, The Discovery Labs, BIOCENTRIQ, FUJIFILM Diosynth Biotechnologies and Exothera, etc.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Plasmid DNA Production in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Plasmid DNA Production companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments according to product types, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, revenue for each segment.
Chapter 7: Europe by type, by application and by country, revenue for each segment.
Chapter 8: Asia Pacific by type, by application and by country/region, revenue for each segment.
Chapter 9: Latin America by type, by application and by country, revenue for each segment.
Chapter 10: Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Plasmid DNA Production revenue, gross margin, and recent development, etc.
Chapter 12: Analyst’s Viewpoints/Conclusions
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Plasmid DNA Production Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Preclinical Plasmid
1.2.3 Clinical Plasmid
1.2.4 Commercial Plasmid
1.3 Market by Application
1.3.1 Global Plasmid DNA Production Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Commercial
1.3.3 Academic Research
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Plasmid DNA Production Market Perspective (2017-2028)
2.2 Plasmid DNA Production Growth Trends by Region
2.2.1 Plasmid DNA Production Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Plasmid DNA Production Historic Market Size by Region (2017-2022)
2.2.3 Plasmid DNA Production Forecasted Market Size by Region (2023-2028)
2.3 Plasmid DNA Production Market Dynamics
2.3.1 Plasmid DNA Production Industry Trends
2.3.2 Plasmid DNA Production Market Drivers
2.3.3 Plasmid DNA Production Market Challenges
2.3.4 Plasmid DNA Production Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Plasmid DNA Production Players by Revenue
3.1.1 Global Top Plasmid DNA Production Players by Revenue (2017-2022)
3.1.2 Global Plasmid DNA Production Revenue Market Share by Players (2017-2022)
3.2 Global Plasmid DNA Production Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Plasmid DNA Production Revenue
3.4 Global Plasmid DNA Production Market Concentration Ratio
3.4.1 Global Plasmid DNA Production Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Plasmid DNA Production Revenue in 2021
3.5 Plasmid DNA Production Key Players Head office and Area Served
3.6 Key Players Plasmid DNA Production Product Solution and Service
3.7 Date of Enter into Plasmid DNA Production Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Plasmid DNA Production Breakdown Data by Type
4.1 Global Plasmid DNA Production Historic Market Size by Type (2017-2022)
4.2 Global Plasmid DNA Production Forecasted Market Size by Type (2023-2028)
5 Plasmid DNA Production Breakdown Data by Application
5.1 Global Plasmid DNA Production Historic Market Size by Application (2017-2022)
5.2 Global Plasmid DNA Production Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Plasmid DNA Production Market Size (2017-2028)
6.2 North America Plasmid DNA Production Market Size by Type
6.2.1 North America Plasmid DNA Production Market Size by Type (2017-2022)
6.2.2 North America Plasmid DNA Production Market Size by Type (2023-2028)
6.2.3 North America Plasmid DNA Production Market Share by Type (2017-2028)
6.3 North America Plasmid DNA Production Market Size by Application
6.3.1 North America Plasmid DNA Production Market Size by Application (2017-2022)
6.3.2 North America Plasmid DNA Production Market Size by Application (2023-2028)
6.3.3 North America Plasmid DNA Production Market Share by Application (2017-2028)
6.4 North America Plasmid DNA Production Market Size by Country
6.4.1 North America Plasmid DNA Production Market Size by Country (2017-2022)
6.4.2 North America Plasmid DNA Production Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Plasmid DNA Production Market Size (2017-2028)
7.2 Europe Plasmid DNA Production Market Size by Type
7.2.1 Europe Plasmid DNA Production Market Size by Type (2017-2022)
7.2.2 Europe Plasmid DNA Production Market Size by Type (2023-2028)
7.2.3 Europe Plasmid DNA Production Market Share by Type (2017-2028)
7.3 Europe Plasmid DNA Production Market Size by Application
7.3.1 Europe Plasmid DNA Production Market Size by Application (2017-2022)
7.3.2 Europe Plasmid DNA Production Market Size by Application (2023-2028)
7.3.3 Europe Plasmid DNA Production Market Share by Application (2017-2028)
7.4 Europe Plasmid DNA Production Market Size by Country
7.4.1 Europe Plasmid DNA Production Market Size by Country (2017-2022)
7.4.2 Europe Plasmid DNA Production Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Plasmid DNA Production Market Size (2017-2028)
8.2 Asia-Pacific Plasmid DNA Production Market Size by Type
8.2.1 Asia-Pacific Plasmid DNA Production Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Plasmid DNA Production Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Plasmid DNA Production Market Share by Type (2017-2028)
8.3 Asia-Pacific Plasmid DNA Production Market Size by Application
8.3.1 Asia-Pacific Plasmid DNA Production Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Plasmid DNA Production Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Plasmid DNA Production Market Share by Application (2017-2028)
8.4 Asia-Pacific Plasmid DNA Production Market Size by Region
8.4.1 Asia-Pacific Plasmid DNA Production Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Plasmid DNA Production Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Plasmid DNA Production Market Size (2017-2028)
9.2 Latin America Plasmid DNA Production Market Size by Type
9.2.1 Latin America Plasmid DNA Production Market Size by Type (2017-2022)
9.2.2 Latin America Plasmid DNA Production Market Size by Type (2023-2028)
9.2.3 Latin America Plasmid DNA Production Market Share by Type (2017-2028)
9.3 Latin America Plasmid DNA Production Market Size by Application
9.3.1 Latin America Plasmid DNA Production Market Size by Application (2017-2022)
9.3.2 Latin America Plasmid DNA Production Market Size by Application (2023-2028)
9.3.3 Latin America Plasmid DNA Production Market Share by Application (2017-2028)
9.4 Latin America Plasmid DNA Production Market Size by Country
9.4.1 Latin America Plasmid DNA Production Market Size by Country (2017-2022)
9.4.2 Latin America Plasmid DNA Production Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Plasmid DNA Production Market Size (2017-2028)
10.2 Middle East & Africa Plasmid DNA Production Market Size by Type
10.2.1 Middle East & Africa Plasmid DNA Production Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Plasmid DNA Production Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Plasmid DNA Production Market Share by Type (2017-2028)
10.3 Middle East & Africa Plasmid DNA Production Market Size by Application
10.3.1 Middle East & Africa Plasmid DNA Production Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Plasmid DNA Production Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Plasmid DNA Production Market Share by Application (2017-2028)
10.4 Middle East & Africa Plasmid DNA Production Market Size by Country
10.4.1 Middle East & Africa Plasmid DNA Production Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Plasmid DNA Production Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Charles River
11.1.1 Charles River Company Details
11.1.2 Charles River Business Overview
11.1.3 Charles River Plasmid DNA Production Introduction
11.1.4 Charles River Revenue in Plasmid DNA Production Business (2017-2022)
11.1.5 Charles River Recent Developments
11.2 Lonza
11.2.1 Lonza Company Details
11.2.2 Lonza Business Overview
11.2.3 Lonza Plasmid DNA Production Introduction
11.2.4 Lonza Revenue in Plasmid DNA Production Business (2017-2022)
11.2.5 Lonza Recent Developments
11.3 Aldevron
11.3.1 Aldevron Company Details
11.3.2 Aldevron Business Overview
11.3.3 Aldevron Plasmid DNA Production Introduction
11.3.4 Aldevron Revenue in Plasmid DNA Production Business (2017-2022)
11.3.5 Aldevron Recent Developments
11.4 Thermo Fisher Scientific
11.4.1 Thermo Fisher Scientific Company Details
11.4.2 Thermo Fisher Scientific Business Overview
11.4.3 Thermo Fisher Scientific Plasmid DNA Production Introduction
11.4.4 Thermo Fisher Scientific Revenue in Plasmid DNA Production Business (2017-2022)
11.4.5 Thermo Fisher Scientific Recent Developments
11.5 Catalent
11.5.1 Catalent Company Details
11.5.2 Catalent Business Overview
11.5.3 Catalent Plasmid DNA Production Introduction
11.5.4 Catalent Revenue in Plasmid DNA Production Business (2017-2022)
11.5.5 Catalent Recent Developments
11.6 The Discovery Labs
11.6.1 The Discovery Labs Company Details
11.6.2 The Discovery Labs Business Overview
11.6.3 The Discovery Labs Plasmid DNA Production Introduction
11.6.4 The Discovery Labs Revenue in Plasmid DNA Production Business (2017-2022)
11.6.5 The Discovery Labs Recent Developments
11.7 BIOCENTRIQ
11.7.1 BIOCENTRIQ Company Details
11.7.2 BIOCENTRIQ Business Overview
11.7.3 BIOCENTRIQ Plasmid DNA Production Introduction
11.7.4 BIOCENTRIQ Revenue in Plasmid DNA Production Business (2017-2022)
11.7.5 BIOCENTRIQ Recent Developments
11.8 FUJIFILM Diosynth Biotechnologies
11.8.1 FUJIFILM Diosynth Biotechnologies Company Details
11.8.2 FUJIFILM Diosynth Biotechnologies Business Overview
11.8.3 FUJIFILM Diosynth Biotechnologies Plasmid DNA Production Introduction
11.8.4 FUJIFILM Diosynth Biotechnologies Revenue in Plasmid DNA Production Business (2017-2022)
11.8.5 FUJIFILM Diosynth Biotechnologies Recent Developments
11.9 Exothera
11.9.1 Exothera Company Details
11.9.2 Exothera Business Overview
11.9.3 Exothera Plasmid DNA Production Introduction
11.9.4 Exothera Revenue in Plasmid DNA Production Business (2017-2022)
11.9.5 Exothera Recent Developments
11.10 WuXi AppTec
11.10.1 WuXi AppTec Company Details
11.10.2 WuXi AppTec Business Overview
11.10.3 WuXi AppTec Plasmid DNA Production Introduction
11.10.4 WuXi AppTec Revenue in Plasmid DNA Production Business (2017-2022)
11.10.5 WuXi AppTec Recent Developments
11.11 Pharmaron
11.11.1 Pharmaron Company Details
11.11.2 Pharmaron Business Overview
11.11.3 Pharmaron Plasmid DNA Production Introduction
11.11.4 Pharmaron Revenue in Plasmid DNA Production Business (2017-2022)
11.11.5 Pharmaron Recent Developments
11.12 OBiO
11.12.1 OBiO Company Details
11.12.2 OBiO Business Overview
11.12.3 OBiO Plasmid DNA Production Introduction
11.12.4 OBiO Revenue in Plasmid DNA Production Business (2017-2022)
11.12.5 OBiO Recent Developments
11.13 Cell Therapies
11.13.1 Cell Therapies Company Details
11.13.2 Cell Therapies Business Overview
11.13.3 Cell Therapies Plasmid DNA Production Introduction
11.13.4 Cell Therapies Revenue in Plasmid DNA Production Business (2017-2022)
11.13.5 Cell Therapies Recent Developments
11.14 AGC Biologics
11.14.1 AGC Biologics Company Details
11.14.2 AGC Biologics Business Overview
11.14.3 AGC Biologics Plasmid DNA Production Introduction
11.14.4 AGC Biologics Revenue in Plasmid DNA Production Business (2017-2022)
11.14.5 AGC Biologics Recent Developments
11.15 Cytiva
11.15.1 Cytiva Company Details
11.15.2 Cytiva Business Overview
11.15.3 Cytiva Plasmid DNA Production Introduction
11.15.4 Cytiva Revenue in Plasmid DNA Production Business (2017-2022)
11.15.5 Cytiva Recent Developments
11.16 Helixmith
11.16.1 Helixmith Company Details
11.16.2 Helixmith Business Overview
11.16.3 Helixmith Plasmid DNA Production Introduction
11.16.4 Helixmith Revenue in Plasmid DNA Production Business (2017-2022)
11.16.5 Helixmith Recent Developments
11.17 ThermoGenesis
11.17.1 ThermoGenesis Company Details
11.17.2 ThermoGenesis Business Overview
11.17.3 ThermoGenesis Plasmid DNA Production Introduction
11.17.4 ThermoGenesis Revenue in Plasmid DNA Production Business (2017-2022)
11.17.5 ThermoGenesis Recent Developments
11.18 Anemocyte
11.18.1 Anemocyte Company Details
11.18.2 Anemocyte Business Overview
11.18.3 Anemocyte Plasmid DNA Production Introduction
11.18.4 Anemocyte Revenue in Plasmid DNA Production Business (2017-2022)
11.18.5 Anemocyte Recent Developments
11.19 CBM
11.19.1 CBM Company Details
11.19.2 CBM Business Overview
11.19.3 CBM Plasmid DNA Production Introduction
11.19.4 CBM Revenue in Plasmid DNA Production Business (2017-2022)
11.19.5 CBM Recent Developments
11.20 Bio Elpida
11.20.1 Bio Elpida Company Details
11.20.2 Bio Elpida Business Overview
11.20.3 Bio Elpida Plasmid DNA Production Introduction
11.20.4 Bio Elpida Revenue in Plasmid DNA Production Business (2017-2022)
11.20.5 Bio Elpida Recent Developments
11.21 Genezen
11.21.1 Genezen Company Details
11.21.2 Genezen Business Overview
11.21.3 Genezen Plasmid DNA Production Introduction
11.21.4 Genezen Revenue in Plasmid DNA Production Business (2017-2022)
11.21.5 Genezen Recent Developments
11.22 CCRM
11.22.1 CCRM Company Details
11.22.2 CCRM Business Overview
11.22.3 CCRM Plasmid DNA Production Introduction
11.22.4 CCRM Revenue in Plasmid DNA Production Business (2017-2022)
11.22.5 CCRM Recent Developments
11.23 RoslinCT
11.23.1 RoslinCT Company Details
11.23.2 RoslinCT Business Overview
11.23.3 RoslinCT Plasmid DNA Production Introduction
11.23.4 RoslinCT Revenue in Plasmid DNA Production Business (2017-2022)
11.23.5 RoslinCT Recent Developments
11.24 GenScript ProBio
11.24.1 GenScript ProBio Company Details
11.24.2 GenScript ProBio Business Overview
11.24.3 GenScript ProBio Plasmid DNA Production Introduction
11.24.4 GenScript ProBio Revenue in Plasmid DNA Production Business (2017-2022)
11.24.5 GenScript ProBio Recent Developments
11.25 Oxford BioMedica
11.25.1 Oxford BioMedica Company Details
11.25.2 Oxford BioMedica Business Overview
11.25.3 Oxford BioMedica Plasmid DNA Production Introduction
11.25.4 Oxford BioMedica Revenue in Plasmid DNA Production Business (2017-2022)
11.25.5 Oxford BioMedica Recent Developments
11.26 Porton Pharma Solutions
11.26.1 Porton Pharma Solutions Company Details
11.26.2 Porton Pharma Solutions Business Overview
11.26.3 Porton Pharma Solutions Plasmid DNA Production Introduction
11.26.4 Porton Pharma Solutions Revenue in Plasmid DNA Production Business (2017-2022)
11.26.5 Porton Pharma Solutions Recent Developments
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
Table 1. Global Plasmid DNA Production Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Preclinical Plasmid
Table 3. Key Players of Clinical Plasmid
Table 4. Key Players of Commercial Plasmid
Table 5. Global Plasmid DNA Production Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 6. Global Plasmid DNA Production Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 7. Global Plasmid DNA Production Market Size by Region (2017-2022) & (US$ Million)
Table 8. Global Plasmid DNA Production Market Share by Region (2017-2022)
Table 9. Global Plasmid DNA Production Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 10. Global Plasmid DNA Production Market Share by Region (2023-2028)
Table 11. Plasmid DNA Production Market Trends
Table 12. Plasmid DNA Production Market Drivers
Table 13. Plasmid DNA Production Market Challenges
Table 14. Plasmid DNA Production Market Restraints
Table 15. Global Plasmid DNA Production Revenue by Players (2017-2022) & (US$ Million)
Table 16. Global Plasmid DNA Production Revenue Share by Players (2017-2022)
Table 17. Global Top Plasmid DNA Production by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Plasmid DNA Production as of 2021)
Table 18. Ranking of Global Top Plasmid DNA Production Companies by Revenue (US$ Million) in 2021
Table 19. Global 5 Largest Players Market Share by Plasmid DNA Production Revenue (CR5 and HHI) & (2017-2022)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Plasmid DNA Production Product Solution and Service
Table 22. Date of Enter into Plasmid DNA Production Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Plasmid DNA Production Market Size by Type (2017-2022) & (US$ Million)
Table 25. Global Plasmid DNA Production Revenue Market Share by Type (2017-2022)
Table 26. Global Plasmid DNA Production Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 27. Global Plasmid DNA Production Revenue Market Share by Type (2023-2028)
Table 28. Global Plasmid DNA Production Market Size by Application (2017-2022) & (US$ Million)
Table 29. Global Plasmid DNA Production Revenue Share by Application (2017-2022)
Table 30. Global Plasmid DNA Production Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 31. Global Plasmid DNA Production Revenue Share by Application (2023-2028)
Table 32. North America Plasmid DNA Production Market Size by Type (2017-2022) & (US$ Million)
Table 33. North America Plasmid DNA Production Market Size by Type (2023-2028) & (US$ Million)
Table 34. North America Plasmid DNA Production Market Size by Application (2017-2022) & (US$ Million)
Table 35. North America Plasmid DNA Production Market Size by Application (2023-2028) & (US$ Million)
Table 36. North America Plasmid DNA Production Market Size by Country (2017-2022) & (US$ Million)
Table 37. North America Plasmid DNA Production Market Size by Country (2023-2028) & (US$ Million)
Table 38. Europe Plasmid DNA Production Market Size by Type (2017-2022) & (US$ Million)
Table 39. Europe Plasmid DNA Production Market Size by Type (2023-2028) & (US$ Million)
Table 40. Europe Plasmid DNA Production Market Size by Application (2017-2022) & (US$ Million)
Table 41. Europe Plasmid DNA Production Market Size by Application (2023-2028) & (US$ Million)
Table 42. Europe Plasmid DNA Production Market Size by Country (2017-2022) & (US$ Million)
Table 43. Europe Plasmid DNA Production Market Size by Country (2023-2028) & (US$ Million)
Table 44. Asia Pacific Plasmid DNA Production Market Size by Type (2017-2022) & (US$ Million)
Table 45. Asia Pacific Plasmid DNA Production Market Size by Type (2023-2028) & (US$ Million)
Table 46. Asia Pacific Plasmid DNA Production Market Size by Application (2017-2022) & (US$ Million)
Table 47. Asia Pacific Plasmid DNA Production Market Size by Application (2023-2028) & (US$ Million)
Table 48. Asia Pacific Plasmid DNA Production Market Size by Region (2017-2022) & (US$ Million)
Table 49. Asia Pacific Plasmid DNA Production Market Size by Region (2023-2028) & (US$ Million)
Table 50. Latin America Plasmid DNA Production Market Size by Type (2017-2022) & (US$ Million)
Table 51. Latin America Plasmid DNA Production Market Size by Type (2023-2028) & (US$ Million)
Table 52. Latin America Plasmid DNA Production Market Size by Application (2017-2022) & (US$ Million)
Table 53. Latin America Plasmid DNA Production Market Size by Application (2023-2028) & (US$ Million)
Table 54. Latin America Plasmid DNA Production Market Size by Country (2017-2022) & (US$ Million)
Table 55. Latin America Plasmid DNA Production Market Size by Country (2023-2028) & (US$ Million)
Table 56. Middle East and Africa Plasmid DNA Production Market Size by Type (2017-2022) & (US$ Million)
Table 57. Middle East and Africa Plasmid DNA Production Market Size by Type (2023-2028) & (US$ Million)
Table 58. Middle East and Africa Plasmid DNA Production Market Size by Application (2017-2022) & (US$ Million)
Table 59. Middle East and Africa Plasmid DNA Production Market Size by Application (2023-2028) & (US$ Million)
Table 60. Middle East and Africa Plasmid DNA Production Market Size by Country (2017-2022) & (US$ Million)
Table 61. Middle East and Africa Plasmid DNA Production Market Size by Country (2023-2028) & (US$ Million)
Table 62. Charles River Company Details
Table 63. Charles River Business Overview
Table 64. Charles River Plasmid DNA Production Product
Table 65. Charles River Revenue in Plasmid DNA Production Business (2017-2022) & (US$ Million)
Table 66. Charles River Recent Developments
Table 67. Lonza Company Details
Table 68. Lonza Business Overview
Table 69. Lonza Plasmid DNA Production Product
Table 70. Lonza Revenue in Plasmid DNA Production Business (2017-2022) & (US$ Million)
Table 71. Lonza Recent Developments
Table 72. Aldevron Company Details
Table 73. Aldevron Business Overview
Table 74. Aldevron Plasmid DNA Production Product
Table 75. Aldevron Revenue in Plasmid DNA Production Business (2017-2022) & (US$ Million)
Table 76. Aldevron Recent Developments
Table 77. Thermo Fisher Scientific Company Details
Table 78. Thermo Fisher Scientific Business Overview
Table 79. Thermo Fisher Scientific Plasmid DNA Production Product
Table 80. Thermo Fisher Scientific Revenue in Plasmid DNA Production Business (2017-2022) & (US$ Million)
Table 81. Thermo Fisher Scientific Recent Developments
Table 82. Catalent Company Details
Table 83. Catalent Business Overview
Table 84. Catalent Plasmid DNA Production Product
Table 85. Catalent Revenue in Plasmid DNA Production Business (2017-2022) & (US$ Million)
Table 86. Catalent Recent Developments
Table 87. The Discovery Labs Company Details
Table 88. The Discovery Labs Business Overview
Table 89. The Discovery Labs Plasmid DNA Production Product
Table 90. The Discovery Labs Revenue in Plasmid DNA Production Business (2017-2022) & (US$ Million)
Table 91. The Discovery Labs Recent Developments
Table 92. BIOCENTRIQ Company Details
Table 93. BIOCENTRIQ Business Overview
Table 94. BIOCENTRIQ Plasmid DNA Production Product
Table 95. BIOCENTRIQ Revenue in Plasmid DNA Production Business (2017-2022) & (US$ Million)
Table 96. BIOCENTRIQ Recent Developments
Table 97. FUJIFILM Diosynth Biotechnologies Company Details
Table 98. FUJIFILM Diosynth Biotechnologies Business Overview
Table 99. FUJIFILM Diosynth Biotechnologies Plasmid DNA Production Product
Table 100. FUJIFILM Diosynth Biotechnologies Revenue in Plasmid DNA Production Business (2017-2022) & (US$ Million)
Table 101. FUJIFILM Diosynth Biotechnologies Recent Developments
Table 102. Exothera Company Details
Table 103. Exothera Business Overview
Table 104. Exothera Plasmid DNA Production Product
Table 105. Exothera Revenue in Plasmid DNA Production Business (2017-2022) & (US$ Million)
Table 106. Exothera Recent Developments
Table 107. WuXi AppTec Company Details
Table 108. WuXi AppTec Business Overview
Table 109. WuXi AppTec Plasmid DNA Production Product
Table 110. WuXi AppTec Revenue in Plasmid DNA Production Business (2017-2022) & (US$ Million)
Table 111. WuXi AppTec Recent Developments
Table 112. Pharmaron Company Details
Table 113. Pharmaron Business Overview
Table 114. Pharmaron Plasmid DNA Production Product
Table 115. Pharmaron Revenue in Plasmid DNA Production Business (2017-2022) & (US$ Million)
Table 116. Pharmaron Recent Developments
Table 117. OBiO Company Details
Table 118. OBiO Business Overview
Table 119. OBiO Plasmid DNA Production Product
Table 120. OBiO Revenue in Plasmid DNA Production Business (2017-2022) & (US$ Million)
Table 121. OBiO Recent Developments
Table 122. Cell Therapies Company Details
Table 123. Cell Therapies Business Overview
Table 124. Cell Therapies Plasmid DNA Production Product
Table 125. Cell Therapies Revenue in Plasmid DNA Production Business (2017-2022) & (US$ Million)
Table 126. Cell Therapies Recent Developments
Table 127. AGC Biologics Company Details
Table 128. AGC Biologics Business Overview
Table 129. AGC Biologics Plasmid DNA Production Product
Table 130. AGC Biologics Revenue in Plasmid DNA Production Business (2017-2022) & (US$ Million)
Table 131. AGC Biologics Recent Developments
Table 132. Cytiva Company Details
Table 133. Cytiva Business Overview
Table 134. Cytiva Plasmid DNA Production Product
Table 135. Cytiva Revenue in Plasmid DNA Production Business (2017-2022) & (US$ Million)
Table 136. Cytiva Recent Developments
Table 137. Helixmith Company Details
Table 138. Helixmith Business Overview
Table 139. Helixmith Plasmid DNA Production Product
Table 140. Helixmith Revenue in Plasmid DNA Production Business (2017-2022) & (US$ Million)
Table 141. Helixmith Recent Developments
Table 142. ThermoGenesis Company Details
Table 143. ThermoGenesis Business Overview
Table 144. ThermoGenesis Plasmid DNA Production Product
Table 145. ThermoGenesis Revenue in Plasmid DNA Production Business (2017-2022) & (US$ Million)
Table 146. ThermoGenesis Recent Developments
Table 147. Anemocyte Company Details
Table 148. Anemocyte Business Overview
Table 149. Anemocyte Plasmid DNA Production Product
Table 150. Anemocyte Revenue in Plasmid DNA Production Business (2017-2022) & (US$ Million)
Table 151. Anemocyte Recent Developments
Table 152. CBM Company Details
Table 153. CBM Business Overview
Table 154. CBM Plasmid DNA Production Product
Table 155. CBM Revenue in Plasmid DNA Production Business (2017-2022) & (US$ Million)
Table 156. CBM Recent Developments
Table 157. Bio Elpida Company Details
Table 158. Bio Elpida Business Overview
Table 159. Bio Elpida Plasmid DNA Production Product
Table 160. Bio Elpida Revenue in Plasmid DNA Production Business (2017-2022) & (US$ Million)
Table 161. Bio Elpida Recent Developments
Table 162. Genezen Company Details
Table 163. Genezen Business Overview
Table 164. Genezen Plasmid DNA Production Product
Table 165. Genezen Revenue in Plasmid DNA Production Business (2017-2022) & (US$ Million)
Table 166. Genezen Recent Developments
Table 167. CCRM Company Details
Table 168. CCRM Business Overview
Table 169. CCRM Plasmid DNA Production Product
Table 170. CCRM Revenue in Plasmid DNA Production Business (2017-2022) & (US$ Million)
Table 171. CCRM Recent Developments
Table 172. RoslinCT Company Details
Table 173. RoslinCT Business Overview
Table 174. RoslinCT Plasmid DNA Production Product
Table 175. RoslinCT Revenue in Plasmid DNA Production Business (2017-2022) & (US$ Million)
Table 176. RoslinCT Recent Developments
Table 177. GenScript ProBio Company Details
Table 178. GenScript ProBio Business Overview
Table 179. GenScript ProBio Plasmid DNA Production Product
Table 180. GenScript ProBio Revenue in Plasmid DNA Production Business (2017-2022) & (US$ Million)
Table 181. GenScript ProBio Recent Developments
Table 182. Oxford BioMedica Company Details
Table 183. Oxford BioMedica Business Overview
Table 184. Oxford BioMedica Plasmid DNA Production Product
Table 185. Oxford BioMedica Revenue in Plasmid DNA Production Business (2017-2022) & (US$ Million)
Table 186. Oxford BioMedica Recent Developments
Table 187. Porton Pharma Solutions Company Details
Table 188. Porton Pharma Solutions Business Overview
Table 189. Porton Pharma Solutions Plasmid DNA Production Product
Table 190. Porton Pharma Solutions Revenue in Plasmid DNA Production Business (2017-2022) & (US$ Million)
Table 191. Porton Pharma Solutions Recent Developments
Table 192. Research Programs/Design for This Report
Table 193. Key Data Information from Secondary Sources
Table 194. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Plasmid DNA Production Market Share by Type: 2021 VS 2028
Figure 2. Preclinical Plasmid Features
Figure 3. Clinical Plasmid Features
Figure 4. Commercial Plasmid Features
Figure 5. Global Plasmid DNA Production Market Share by Application: 2021 VS 2028
Figure 6. Commercial Case Studies
Figure 7. Academic Research Case Studies
Figure 8. Others Case Studies
Figure 9. Plasmid DNA Production Report Years Considered
Figure 10. Global Plasmid DNA Production Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 11. Global Plasmid DNA Production Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 12. Global Plasmid DNA Production Market Share by Region: 2021 VS 2028
Figure 13. Global Plasmid DNA Production Market Share by Players in 2021
Figure 14. Global Top Plasmid DNA Production Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Plasmid DNA Production as of 2021)
Figure 15. The Top 10 and 5 Players Market Share by Plasmid DNA Production Revenue in 2021
Figure 16. North America Plasmid DNA Production Market Size YoY (2017-2028) & (US$ Million)
Figure 17. North America Plasmid DNA Production Market Size Market Share by Type (2017-2028)
Figure 18. North America Plasmid DNA Production Market Size Market Share by Application (2017-2028)
Figure 19. North America Plasmid DNA Production Market Size Share by Country (2017-2028)
Figure 20. United States Plasmid DNA Production Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. Canada Plasmid DNA Production Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. Europe Plasmid DNA Production Market Size YoY (2017-2028) & (US$ Million)
Figure 23. Europe Plasmid DNA Production Market Size Market Share by Type (2017-2028)
Figure 24. Europe Plasmid DNA Production Market Size Market Share by Application (2017-2028)
Figure 25. Europe Plasmid DNA Production Market Size Share by Country (2017-2028)
Figure 26. Germany Plasmid DNA Production Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. France Plasmid DNA Production Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. U.K. Plasmid DNA Production Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Italy Plasmid DNA Production Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Russia Plasmid DNA Production Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Nordic Countries Plasmid DNA Production Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Asia-Pacific Plasmid DNA Production Market Size YoY (2017-2028) & (US$ Million)
Figure 33. Asia Pacific Plasmid DNA Production Market Size Market Share by Type (2017-2028)
Figure 34. Asia Pacific Plasmid DNA Production Market Size Market Share by Application (2017-2028)
Figure 35. Asia Pacific Plasmid DNA Production Market Size Share by Region (2017-2028)
Figure 36. China Plasmid DNA Production Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Japan Plasmid DNA Production Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. South Korea Plasmid DNA Production Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Southeast Asia Plasmid DNA Production Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. India Plasmid DNA Production Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Australia Plasmid DNA Production Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Latin America Plasmid DNA Production Market Size YoY (2017-2028) & (US$ Million)
Figure 43. Latin America Plasmid DNA Production Market Size Market Share by Type (2017-2028)
Figure 44. Latin America Plasmid DNA Production Market Size Market Share by Application (2017-2028)
Figure 45. Latin America Plasmid DNA Production Market Size Share by Country (2017-2028)
Figure 46. Mexico Plasmid DNA Production Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 47. Brazil Plasmid DNA Production Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 48. Middle East & Africa Plasmid DNA Production Market Size YoY (2017-2028) & (US$ Million)
Figure 49. Middle East and Africa Plasmid DNA Production Market Size Market Share by Type (2017-2028)
Figure 50. Middle East and Africa Plasmid DNA Production Market Size Market Share by Application (2017-2028)
Figure 51. Middle East and Africa Plasmid DNA Production Market Size Share by Country (2017-2028)
Figure 52. Turkey Plasmid DNA Production Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 53. Saudi Arabia Plasmid DNA Production Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 54. UAE Plasmid DNA Production Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 55. Charles River Revenue Growth Rate in Plasmid DNA Production Business (2017-2022)
Figure 56. Lonza Revenue Growth Rate in Plasmid DNA Production Business (2017-2022)
Figure 57. Aldevron Revenue Growth Rate in Plasmid DNA Production Business (2017-2022)
Figure 58. Thermo Fisher Scientific Revenue Growth Rate in Plasmid DNA Production Business (2017-2022)
Figure 59. Catalent Revenue Growth Rate in Plasmid DNA Production Business (2017-2022)
Figure 60. The Discovery Labs Revenue Growth Rate in Plasmid DNA Production Business (2017-2022)
Figure 61. BIOCENTRIQ Revenue Growth Rate in Plasmid DNA Production Business (2017-2022)
Figure 62. FUJIFILM Diosynth Biotechnologies Revenue Growth Rate in Plasmid DNA Production Business (2017-2022)
Figure 63. Exothera Revenue Growth Rate in Plasmid DNA Production Business (2017-2022)
Figure 64. WuXi AppTec Revenue Growth Rate in Plasmid DNA Production Business (2017-2022)
Figure 65. Pharmaron Revenue Growth Rate in Plasmid DNA Production Business (2017-2022)
Figure 66. OBiO Revenue Growth Rate in Plasmid DNA Production Business (2017-2022)
Figure 67. Cell Therapies Revenue Growth Rate in Plasmid DNA Production Business (2017-2022)
Figure 68. AGC Biologics Revenue Growth Rate in Plasmid DNA Production Business (2017-2022)
Figure 69. Cytiva Revenue Growth Rate in Plasmid DNA Production Business (2017-2022)
Figure 70. Helixmith Revenue Growth Rate in Plasmid DNA Production Business (2017-2022)
Figure 71. ThermoGenesis Revenue Growth Rate in Plasmid DNA Production Business (2017-2022)
Figure 72. Anemocyte Revenue Growth Rate in Plasmid DNA Production Business (2017-2022)
Figure 73. CBM Revenue Growth Rate in Plasmid DNA Production Business (2017-2022)
Figure 74. Bio Elpida Revenue Growth Rate in Plasmid DNA Production Business (2017-2022)
Figure 75. Genezen Revenue Growth Rate in Plasmid DNA Production Business (2017-2022)
Figure 76. CCRM Revenue Growth Rate in Plasmid DNA Production Business (2017-2022)
Figure 77. RoslinCT Revenue Growth Rate in Plasmid DNA Production Business (2017-2022)
Figure 78. GenScript ProBio Revenue Growth Rate in Plasmid DNA Production Business (2017-2022)
Figure 79. Oxford BioMedica Revenue Growth Rate in Plasmid DNA Production Business (2017-2022)
Figure 80. Porton Pharma Solutions Revenue Growth Rate in Plasmid DNA Production Business (2017-2022)
Figure 81. Bottom-up and Top-down Approaches for This Report
Figure 82. Data Triangulation
Figure 83. Key Executives Interviewed